Teva wins appeal over thyroid drug at Fed Circuit

10-08-2020

Muireann Bolger

Teva wins appeal over thyroid drug at Fed Circuit

Bill Perry / Shutterstock.com

In a victory for Teva Pharmaceuticals, the US Court of Appeals for the Federal Circuit dismissed IBSA Institut Biochimique’s appeal against a ruling that held parts of its patent invalid.


Teva, Federal Circuit, Delaware, patent, infringement, IBSA Institut Biochimique, Tirosint, Italian, thyroid

LSIPR